|
Real-time Estimate
Cboe BZX
01:04:19 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 59.34 USD | +0.37% |
|
+9.57% | +51.06% |
| 04/09 | Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing | MT |
| 02/09 | Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 3,007 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 52.9% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,855 | 2,781 | 2,686 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 52.45% | -2.6% | -3.4% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 560x | 141x | 84.9x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 5.19x | 4.63x | 4.05x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 0x | 1.3x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 4.96x | 4.42x | 3.93x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.71x | 4.09x | 3.51x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 32.6x | 27.3x | 21.6x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 249x | 111x | 63.1x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 53.8x | 69.4x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 1.86% | 1.44% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.4186 | 0.6961 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.2 | 679.7 | 765.4 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 101.7 | 124.2 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.55 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.112 | 20.78 | 35.25 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -152.1 | -226.3 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 59.12 | 59.12 | 59.12 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 559.95x | 4.71x | 32.63x | -.--% | 300.72Cr | |
| 28.96x | 4x | 15.46x | 2.51% | 18TCr | |
| 19.63x | 3.58x | 12.79x | 3.04% | 12TCr | |
| 16.94x | 0.2x | 12.43x | 0.77% | 5.9TCr | |
| 34.95x | 3.39x | 11.6x | 2.16% | 4.94TCr | |
| 27.72x | 6.83x | 17.58x | 1.44% | 4.86TCr | |
| 35.25x | 6.2x | 19.46x | -.--% | 3.32TCr | |
| 41.47x | 1.23x | 11.35x | 0.23% | 2.82TCr | |
| 42.75x | 7.5x | 26.89x | 0.25% | 2.58TCr | |
| 50.01x | 6.74x | 21.68x | 0.42% | 2.19TCr | |
| Average | 85.76x | 4.44x | 18.19x | 1.08% | 5.65TCr | |
| Weighted average by Cap. | 31.43x | 3.96x | 15.31x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
